Link Cell Therapies: Funding, Investors & Team (Sep 2026)
Link Cell Therapies develops engineered cell therapy technologies intended to create targeted CAR T-based treatments for cancer. The company applies proprietary logic-gating methods that require co-expression of multiple cancer antigens to activate therapeutic T cells, aiming to focus immune cell activity on tumor cells while reducing effects on non-cancerous tissues. Its work spans programs for solid tumors and certain hematologic cancers, with lead candidates progressing through preclinical development and preparation for clinical research. Link Cell Therapies also explores additional platforms and therapeutic programs that build on its core targeting technology to expand applications of engineered cellular therapies.
Link Cell Therapies has raised $60.0M across 1 funding round on record, the most recent a Series A of $60.0M announced in Dec 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Link Cell Therapies Company Profile and Key Stats
Latest funding round on record: Dec 2025.
Link Cell Therapies Funding Rounds
Link Cell Therapies Founders and Leadership Team
Contact details for the Link Cell Therapies team: 1 of 1 has an email address on file.
Start 14-day free trial →Link Cell Therapies Funding Compared to Other Biotechnology Startups
Link Cell Therapies' latest round of $60.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Link Cell Therapies in Biotechnology and San Francisco
Companies Similar to Link Cell Therapies
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Link Cell Therapies Funding FAQs
What does Link Cell Therapies do?
Link Cell Therapies develops engineered cell therapy technologies intended to create targeted CAR T-based treatments for cancer. The company applies proprietary logic-gating methods that require co-expression of multiple cancer antigens to activate therapeutic T cells, aiming to focus immune cell activity on tumor cells while reducing effects on non-cancerous tissues. Its work spans programs for solid tumors and certain hematologic cancers, with lead candidates progressing through preclinical development and preparation for clinical research. Link Cell Therapies also explores additional platforms and therapeutic programs that build on its core targeting technology to expand applications of engineered cellular therapies.
How much funding has Link Cell Therapies raised?
Link Cell Therapies has raised $60.0M across 1 round on record. The most recent is a Series A of $60.0M announced in Dec 2025.
When did Link Cell Therapies last raise funding?
Link Cell Therapies' most recent funding round on record is a Series A of $60.0M, announced in Dec 2025.
Who founded Link Cell Therapies?
FundedIQ lists Robbie Majzner (Founder) at Link Cell Therapies.
Where is Link Cell Therapies headquartered?
Link Cell Therapies is based in San Francisco, California, United States.
How many employees does Link Cell Therapies have?
Link Cell Therapies is in the 11-50 employee band.
How does Link Cell Therapies' funding compare to other Biotechnology startups?
Link Cell Therapies' latest round of $60.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Link Cell Therapies Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Link Cell Therapies is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.